Bormioli Pharma aims to ensure the highest standard of professional competence for its customers, including in terms of quality, integrity and ethical behavior. In this section you can find the company's Code of Ethics, the Sustainability Report, the Corporate Safety and Environmental Policy and the Statement Against Modern Slavery Practices.

The Bormioli Pharma Group has a Code of Ethics which is an integral and substantial part of its Organization, Management and Control Model and encompasses the ethical principles and rules of conduct which the Bormioli Pharma Group envisions for itself, setting out the general discipline to which all those who work in the corporate environment are subject.

To further protect all stakeholders, the Bormioli Pharma Group has adopted a Whistleblowing Procedure, adapting to the changes introduced by Directive (EU) 2019/1937 (the so-called EU Whistleblowing Directive) and the 2017 legislation on "Provisions for the protection of the authors of reports of crimes or irregularities of which they have become aware in the context of a public or private employment relationship."

This Whistleblowing Procedure is configured as an integral part of the Organization Model, and establishes the prerequisites and methods through which employees, collaborators and Third Parties can report to the Supervisory Board suspicions of any illegal conduct carried out in violation of the requirements of the Model itself, as well as facts and/or behaviors involving any of the crimes mentioned in Legislative Decree No. 231 of 2001 and/or other activities that do not comply with laws, regulations, internal procedures and company policies.

These reports can be made by employees, contractors and Third Parties through a dedicated portal available at the following link: https://bormiolipharma.integrityline.com

The EQS Integrity Line portal is intended to provide any party, including customers and suppliers, with the opportunity to submit reports, including anonymously, concerning behaviors, risks, offences or irregularities, which either occurred or were attempted, to the detriment of the interests of Bormioli Pharma Group, or, in any case, liable to violate the Model and Code of Ethics.

In addition, there remains the possibility of making reports by registered letter with return receipt, anonymously or otherwise, to the following address: Viale Giovanni Falcone no. 48/A-43122, Parma (PR), Italy, to the attention of the Supervisory Board.

As a supplier of packaging for pharmaceutical use, we strive to offer solutions that have a positive effect on people's well-being and the future of our planet. Therefore, through the Sustainability Report report, we measure and communicate both internal and external, performance against our sustainable development goals to our stakeholders.

The Corporate Safety and Environmental Policy encapsulates the criteria that guide us in managing Quality, Safety and Environmental procedures, the same as those described by ISO 9001, ISO 15378, ISO 13485, ISO 45001 and ISO 14001. To ensure compliance with these criteria, our Systems are subjected to regular checking by one of the leading international independent certification bodies.